Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Colloquium focuses on rural education
2012-10-10

Some of the international delegates during the second annual colloquium on rural education recently held at the Qwaqwa Campus.
10 October 2012

 The second edition of the Sustainable Rural Learning Ecologies (SuRLEc) Colloquium was held at the University of the Free State's Qwaqwa Campus this week. This three-day international event provided the Faculty of Education's postgraduate students with a platform to present their research and to learn from experienced researchers from all over the world.

In his opening address, the Faculty's Programme Head, Dr Dipane Hlalele, challenged all delegates to translate their research into achievable goals to address all the challenges facing rural education.

"Excellence in teaching and learning in a rural context remains a challenge for all sectors and levels of the education endeavour," Dr Hlalele said.

"Urban and metropolitan schools, colleges and universities may unintentionally structure their learning programmes in such a manner that they neglect rural attributes. This results in the marginalising of learners and students from rural environments. To complete the loop, these institutions are more likely to fail in preparing graduates for decisive contributions to sustainable rural learning ecologies," Dr Hlalele added.

The colloquium was officially opened by the Vice-Rector: External Relations, Dr Choice Makhetha, who highlighted the fact that the UFS was already doing its bit in levelling the learning playfields in higher education.

"We are aware that many of our students who come from disadvantaged backgrounds find it hard to cope at university. As a result, we are not waiting for them to come through to us. We are already in partnership with a number of schools where we help learners to improve their results," Dr Makhetha said.

The crucial role played by rural teachers was celebrated during a gala dinner to honour and acknowledge their efforts despite a myriad of daily challenges.

Ms Jabulile Mabaso (The Mills Primary Farm School) was honoured for 'Excellence in multi-grade teaching in Foundation and Intermediate phases'. Ms Rekha Mathew (Sibonakaliso Primary Farm School) and Mr Andries Motsoere (Tshebedisano Primary Farm School) were awarded for 'Excellence in managing multi-grade curriculum'.

The 2012 SuRLEc Honorary Award went to Ms Motshedisi Damane for her valuable contribution to the development of rural education in the Thabo Mofutsanyana Education District. Last year's recipient was the Dean of the Faculty of Education, Professor Dennis Francis.

Delegates and keynote speakers came from Thailand, Malaysia, the Unites States of America as well as the SADC countries of Botswana, Zimbabwe and Lesotho. South Africa was represented by the Universities of the North-West, Limpopo, KwaZulu-Natal and CUT, amongst others.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept